Literature DB >> 15925536

Should activin betaC be more than a fading snapshot in the activin/TGFbeta family album?

Christopher M Butler1, Elspeth J Gold, Gail P Risbridger.   

Abstract

The activin growth factors consist of dimeric proteins made up of activin beta subunits and have been shown to be essential regulators of diverse systems in physiology. Four subunits are known to be expressed in mammalian cells: betaA, betaB, betaC, and betaE. Surprisingly, deletion of activin betaC and betaE subunits in vivo does not affect embryonic development or adult physiology which has led to the activin betaC and betaE subunits being regarded as non-essential and unimportant. The steady accumulation of circumstantial evidence to the contrary has led this lab to reassess the role of the activin betaC subunit. Activin betaC protein is expressed more widely than indicated by mRNA localisation. Experiments overexpressing activin betaC subunit or adding exogenous Activin C in vitro are contradictory but suggest roles for activin betaC in regulating Activin A action in apoptosis and homeostasis. Sequestration of betaA subunits by dimerisation with betaC subunits to form Activin AC represents an intracellular regulator of Activin A bioactivity. Activins play a pivotal role in normal physiology and carcinogenesis, so any molecule, such as the activin betaC subunit, that can affect activin action is potentially significant. Advancing our understanding of the physiological role of the activin betaC subunit requires new tools and reagents. Direct detection of the Activin AC dimer will be essential and will necessitate the purification of heteromeric Activin AC protein. In addition, there is a need for the development of an in vivo model of activin betaC subunit overexpression. With development of these tools, research into activin action in development and physiology can expand to include the less well understood members of the activin family such as activin betaC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15925536     DOI: 10.1016/j.cytogfr.2005.04.005

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  8 in total

1.  Immunohistochemical labeling of the inhibin/activin betaC subunit in normal human placental tissue and chorionic carcinoma cell lines.

Authors:  Tobias Weissenbacher; Ansgar Brüning; Tanja Kimmich; Josef Makovitzky; Andrea Gingelmaier; Ioannis Mylonas
Journal:  J Histochem Cytochem       Date:  2010-05-10       Impact factor: 2.479

Review 2.  Novel therapeutic targets in myeloma bone disease.

Authors:  S L Webb; C M Edwards
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

3.  Activins and follistatins: Emerging roles in liver physiology and cancer.

Authors:  Emanuel Kreidl; Deniz Oztürk; Thomas Metzner; Walter Berger; Michael Grusch
Journal:  World J Hepatol       Date:  2009-10-31

4.  Over-Expression of Activin-βC Is Associated with Murine and Human Prostate Disease.

Authors:  Edward C Ottley; Karen L Reader; Kailun Lee; Francesco E Marino; Helen D Nicholson; Gail P Risbridger; Elspeth Gold
Journal:  Horm Cancer       Date:  2017-01-23       Impact factor: 3.869

5.  The orphan ligand, activin C, signals through activin receptor-like kinase 7.

Authors:  Erich J Goebel; Luisina Ongaro; Emily C Kappes; Kylie Vestal; Elitza Belcheva; Roselyne Castonguay; Ravindra Kumar; Daniel J Bernard; Thomas B Thompson
Journal:  Elife       Date:  2022-06-23       Impact factor: 8.713

Review 6.  Activins and activin antagonists in hepatocellular carcinoma.

Authors:  Alev Deli; Emanuel Kreidl; Stefan Santifaller; Barbara Trotter; Katja Seir; Walter Berger; Rolf Schulte-Hermann; Chantal Rodgarkia-Dara; Michael Grusch
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

7.  Evidence of inhibin/activin subunit betaC and betaE synthesis in normal human endometrial tissue.

Authors:  Ioannis Mylonas; Ansgar Brüning; Naim Shabani; Susanne Kunze; Markus S Kupka
Journal:  Reprod Biol Endocrinol       Date:  2010-11-19       Impact factor: 5.211

8.  SNPs in the TGF-β signaling pathway are associated with increased risk of brain metastasis in patients with non-small-cell lung cancer.

Authors:  Qianxia Li; Huanlei Wu; Bei Chen; Guangyuan Hu; Liu Huang; Kai Qin; Yu Chen; Xianglin Yuan; Zhongxing Liao
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.